MedPath

MEZEREX CAPSULES

Registration Number: MAL23056108TC

Approved
Approval ID

db3c5f81da4f4009

Registration Number

MAL23056108TC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types5 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (5)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
300 CapsulesAvailable
Package Size: 300 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (14)

Cornus officinalisActive
Schisandra chinensisActive
Broussonetia papyriferaActive
Monograph: broussonetia papyrifera
Dioscorea oppositaActive
Monograph: dioscorea opposita
Achyranthes bidentataActive
Monograph: achyranthes bidentata
Poria cocosActive
Monograph: poria cocos
Foeniculum vulgareActive
Monograph: foeniculum vulgare
Rehmannia GlutinosaActive
Ziziphus jujubaActive
Monograph: ziziphus jujuba
Eucommia ulmoidesActive
Morinda officinalisActive
Monograph: morinda officinalis
Polygala tenuifoliaActive
Acorus tatarinowiiActive
Monograph: acorus tatarinowii
Lycium barbarumActive
Monograph: lycium barbarum

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEZEREX CAPSULES - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform